Vicus Capital Trims Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Vicus Capital lowered its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 44.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,930 shares of the company’s stock after selling 2,330 shares during the quarter. Vicus Capital’s holdings in Procter & Gamble were worth $508,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Steele Capital Management Inc. purchased a new stake in shares of Procter & Gamble in the first quarter valued at approximately $204,000. GAMMA Investing LLC lifted its holdings in shares of Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares during the period. Consilio Wealth Advisors LLC grew its position in shares of Procter & Gamble by 27.7% during the 1st quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock worth $283,000 after buying an additional 379 shares in the last quarter. AMF Tjanstepension AB raised its holdings in shares of Procter & Gamble by 416.1% in the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after acquiring an additional 1,466,115 shares in the last quarter. Finally, Talbot Financial LLC lifted its stake in Procter & Gamble by 1.5% in the first quarter. Talbot Financial LLC now owns 65,600 shares of the company’s stock worth $10,644,000 after acquiring an additional 950 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of NYSE:PG traded up $0.82 on Tuesday, hitting $170.36. 2,762,308 shares of the company were exchanged, compared to its average volume of 6,667,838. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The stock’s 50 day moving average price is $171.82 and its 200 day moving average price is $167.33. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The firm has a market capitalization of $402.07 billion, a P/E ratio of 27.76, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the business earned $1.83 EPS. The company’s quarterly revenue was down .6% compared to the same quarter last year. Sell-side analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.36%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 65.69%.

Insider Activity

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 96,000 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the sale, the chief executive officer now directly owns 13,721 shares of the company’s stock, valued at approximately $2,332,570. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the sale, the chief executive officer now owns 13,721 shares in the company, valued at approximately $2,332,570. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock valued at $65,140,718 in the last ninety days. Insiders own 0.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on PG. BNP Paribas initiated coverage on shares of Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price target for the company. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Morgan Stanley lifted their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday. Piper Sandler started coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective for the company. Finally, DA Davidson lifted their target price on Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $177.00.

View Our Latest Report on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.